KatherineEmbryBungeMD

Assistant Professor, Ob/Gyn & Reproductive Science, University of Pittsburgh School of Medicine

Dr. Bunge is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1300 Oxford Drive
Ste 1100
Bethel Park, PA 15102
Phone+1 412-641-8851

Fax+1 412-641-8858

McGaw Medical Center of Northwestern UniversityResidency, Obstetrics and Gynecology, 2002 - 2006
Johns Hopkins University School of MedicineClass of 2002

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Most Compassionate Doctor American Registry
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

PubMed

Sofosbuvir/Velpatasvir Pharmacokinetics, Safety, and Efficacy in Pregnant People with Hepatitis C Virus.
Catherine A Chappell, Jennifer J Kiser, Kristina M Brooks, Riley Randolph, Ingrid S Macio
Clinical Infectious Diseases. 2024-12-17
Enhanced D614G and Omicron Variants Antibody Persistence in Infants at 2 Months of Age Following Maternal mRNA Booster Vaccination During Pregnancy or Postpartum.
Flor M Munoz, Richard Beigi, Christine M Posavad, Clifton Kelly, Martina L Badell
The Pediatric Infectious Disease Journal. 2024-11-01
Phase 1 randomized pharmacokinetic and safety study of a 90-day tenofovir vaginal ring in the United States.
Albert Y Liu, Holly Gundacker, Barbra Richardson, Beatrice A Chen, Craig Hoesley
Journal of the International AIDS Society. 2024-03-01

NIH-Funded Clinical Trial to Test PrEP, Dapivirine Ring for Safety in Pregnant WomenFebruary 10th, 2020
Making Clinical Trials of PrEP More Inclusive of Women, No Matter Their Pregnancy StatusSeptember 25th, 2018
HIV Prevention Dapivirine Vaginal Ring Found Safe and Acceptable in US Adolescent GirlsJuly 25th, 2017